Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Go back to Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 5.55 +0.11 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.44 | 52 Week High | $18.00 | |||
| Open | $5.50 | 52 Week Low | $6.91 | |||
| Day High | $5.59 | P/E | N/A | |||
| Day Low | $5.39 | EPS | $-0.67 | |||
| Volume | 569,036 | |||||
